Role of endogenous glutathione in the oxidation of dopamine

Journal of Neurochemistry

Volumn 71, Issue 5, 1998, Pages 2071-2078

  Rabinovic, Ariel D ^a   Hastings, Teresa G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Buthionine sulfoximine; Cysteinyl catechols; Oxidative stress; Parkinson's disease; Quinone; Reactive oxygen species

Indexed keywords

DOPAMINE; GLUTATHIONE;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; GLUTATHIONE METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0031723859     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71052071.x     Document Type: Article

References (59)

1. Andersen J. K., Mo J. Q., Hom D. G., Lee F. Y., Harnish P., Hamill R. W., and McNeill T. H. (1996) Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J. Neurochem. 67, 2164-2171.
2. Aniya Y. and Daido A. (1994) Activation of microsomal glutathione S-transferase in tert-butyl hydroperoxide-induced oxidative stress of isolated rat liver. Jpn. J. Pharmacol. 66, 123-130.
3. Awad J. A., Burk R. F., and Roberts L. J. II (1994) Effect of selenium deficiency and glutathione-modulating agents on diquat toxicity and lipid peroxidation in rats. J. Pharmacol. Exp. Ther. 270, 858-864.
4. Boyland E. and Chasseaud L. F. (1966) Enzyme-catalyzed conjugation of glutathione with unsaturated compounds. Biochem. J. 104, 95-102.
5. Chan H. M., Tabarrok R., Tamura Y., and Cherian G. (1992) The relative importance of glutathione and metallothionein on protection of hepatotoxicity of menadione in rats. Chem. Biol. Interact. 84, 113-124.
6. Chance B., Sies H., and Boveris A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605.
7. Cohen G. and Heikkila R. E. (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and other related cytotoxic agents. J. Biol. Chem. 249, 2447-2452.
8. Crawford D. R. and Davies K.J. (1994) Adaptive response and oxidative stress. Environ. Health Perspect. Suppl. 102, 25-28.
9. Desole M. S., Misle M., Esposito G., Mighell R., Fresu L., De Natale G., and Miele E. (1994) Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese. Arch. Toxicol. 68, 566-570.
10. Desole M. S., Esposito G., Might R., Fresu L., Sircana S., Zangani D., Miele M., and Miele E. (1995) Cellular defense mechanisms in the striatum of young and aged rats subchronically exposed to manganese. Neuropharmacology 3, 289-295.
11. Di Monte D., Ross D., Bellomo G., Eklöw L., and Orrenius S. (1984) Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. Arch. Biochem. Biophys. 235, 334-342.
12. Fernandes R. S. and Cotter T. G. (1994) Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem. Pharmacol. 48, 675-681.
13. Filloux F. and Townsend J. J. (1993) Pre-and postsynaptic neurotoxic effect of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119, 79-88.
14. Fornstedt B. and Carlsson A. (1989) A marked increase in 5-S-cysteinyl-dopamine in guinea-pig striatum following reserpine treatment. J. Neural Transm. 76, 155-161.
15. Fornstedt B. and Carlsson A. (1991) Vitamin C deficiency facilitated 5-S-cysteinyldopamine formation in guinea-pig striatum. J. Neurochem. 56, 407-414.
16. Fornstedt B., Bergh I., Rosengren E., and Carlsson A. (1990a) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4 dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J. Neurochem. 54, 578-586.
17. Fornstedt B., Pileblad E., and Carlsson A. (1990e) In vivo autoxidation of dopamine in guinea-pig striatum increases with age. J. Neurochem. 55, 655-659.
18. Gibbs W. R. G. and Lees A. J. (1988) The relevance of Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51, 745-752.
19. Götz M. E., Künig G., Riederer P., and Youdim M. B. H. (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 63, 37-122.
20. Graham D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
21. Griffith O. W. (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
22. Griffith O. W. and Meister A. (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butylhomocysteine sulfoximine). J. Biol. Chem. 254, 7558-7560.
23. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
24. Han S.-K., Mytilineou C., and Cohen G. (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66, 501-510.
25. 3H]-dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
26. Hastings T. G., Lewis D. A., and Zigmond M. J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1956-1961.
27. Heikkila R. E. and Cabbat F. S. (1977) Chemilumincscence from 6-hydroxydopamine: involvement of hydrogen peroxide, the superoxide radical and the hydroxyl radical, a potential role for singlet oxygen. Res. Commun. Chem. Pathol. Pharmacol. 17, 649-662.
28. Hornykiewicz O. (1966) Dopamine (3-hydroxytyramine) and brain functions. Pharmacol. Rev. 18, 925-964.
29. Janssen Y. M., Van Houten B., Borm P. J., and Mossman B. T. (1993) Cell and tissue responses to oxidative damage. Lab. Invest. 69, 261-274.
30. Jenner P., Schapira A. H. V., and Marsden C. D. (1992) New insights into the cause of Parkinson's disease. Neurology 42, 2241-2250.
31. Jurma O. P., Hom D. G., and Andersen J. K. (1997) Decreased glutathione results in calcium-mediated cell death in PC12. Free Radic. Biol. Med. 23, 1055-1066.
32. Kish S. J., Morito C., and Hornykiewicz O. (1985) Glutathione peroxide activity in Parkinson's disease brain. Neurosci. Lett. 58, 343-346.
33. Kosower N. S. and Kosower E. M. (1978) The glutathione status of cells. Int. Rev. Cytol. 54, 109-160.
34. Maker H. S., Weiss C., Silides D. J., and Cohen G. (1981) Coupling of dopamine oxidation and monoamine oxidase activity to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36, 589-593.
35. Meister A. (1975) Biochemistry of glutathione, in Metabolism of Sulfur Compounds (Greenberg D. M., ed). pp. 101-188. Academic Press, New York.
36. Meister A. (1991) Glutathione deficiency produced by inhibition of its synthesis and its reversal; applications in research and therapy. Pharmacol. Ther. 51, 155-194.
37. Meister A. (1994) Glutathione, ascorbate and cellular protection. Cancer Res. 54(Suppl.), 1969-1975.
38. Meister A. (1995) Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 127, 35-42.
39. Mena M. A., Pardo B., Casarejos M. J., Fahn S., and De Yebenes J. G. (1992) Neurotoxicity of levodopa on catecholamine-rich neurons. Mov. Disord. 7, 23-51.
40. Michel P. P. and Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428-435.
41. Offen D., Ziv I., Sternin H., Melamed E., and Hochman A. (1996) Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 141, 32-39.
42. Perry T. L., Godin D. V., and Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
43. Pileblad E. and Magnusson T. (1990) Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one. Life Sci. 47, 2333-2342.
44. Pileblad E., Magnusson T., and Fornstedt B. (1989) Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52, 978-980.
45. Rabinovic A. D., Zigmond M. J., and Hastings T. G. (1996) Early indices of oxidative stress: immediate response to neurotoxic levels of exogenous dopamine. Soc. Neurosci. Abstr. 22, 221.
46. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
47. Rosenberg P.A. (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8, 2887-2894.
48. Rosengren E., Linder-Eliasson E., and Carlsson A. (1985) Detection of 5-S-cysteinyldopamine in human brain. J. Neural Transm. 63, 247-253.
49. Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R., and Gibb J. W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
50. Seaton T. A., Jenner P., and Marsden C. D. (1996) Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat. Biochem. Pharmacol. 52, 1657-1663.
51. Shertzer H. G., Bannenberg G. L., Zhu H., Liu R. M., and Moldeus P. (1994) The role of thiols in mitochondrial susceptibility to iron and tert-butyl hydroperoxide-mediated toxicity in cultured mouse hepatocytes. Chem. Res. Toxicol. 7, 358-366.
52. 2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Radic. Biol. Med. 15, 57-67.
53. Tanaka M., Sotomatsu A., Kanai H., and Hirai S. (1991) DOPA and dopamine cause cultured neuronal death in the presence of iron. J. Neurol. Sci. 101, 198-203.
54. Toffa S., Kunikowska G. M., Zeng B.-Y., Jenner P., and Marsden C. D. (1997) Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J. Neural Transm. 104, 67-75.
55. Vessey D. A., Lee K. H., and Blacker K. L. (1992) Characterization of the oxidative stress initiated in cultured human keratinocytes by treatment with peroxides. J. Invest. Dermatol. 99, 858-863.
56. Weinberger J., Nieves-Rosa J., and Cohen G. (1985) Nerve terminal damage in cerebral ischemia protective effect of alpha-methyl-O-para-tyrosine. Stroke 16, 864-870.
57. + toxicity in nigral dopaminergic neurones. Neuroreport 7, 921-923.
58. Zhang F. and Dryhurst G. (1994) Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. J. Med. Chem. 37, 1084-1098.
59. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., and Barzilai A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenic mechanism in Parkinson's disease. Neurosci. Lett. 170, 136-140.